2021 annual financial data
Gain Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -7,494.62%.
Operating income was -13,826,173 USD and net income was -13,890,606 USD.
Operating cash flow was -12,365,670 USD.
Get free Gain Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 164,994 USD
- Operating income
- -13,826,173 USD
- Net income
- -13,890,606 USD
- Operating cash flow
- -12,365,670 USD